Compare flow cytometry, luciferase and LDH-based immune cell-mediated cytotoxicity assays for CAR-T, CAR-NK, ADCC and T-cell engager research, and identify the best solution for your application.

Researchers often struggle to quantify proteins present at extremely low concentrations. Discover how NexaTag® ultrasensitive qIPCR technology enables highly specific, femtogram-level protein detection using minimal sample volume for biomarker, immuno-oncology and translational research.

Phosphoinositides (PIPs) are low-abundance but highly dynamic signalling lipids that regulate essential cellular processes including PI3K/AKT signalling, membrane trafficking, autophagy and cytoskeletal remodelling. Even subtle changes in PIP abundance can profoundly influence disease mechanisms, making accurate quantification critical for cancer, neuroscience, immunology and metabolic research.

Stay ahead in your research with your monthly Tebubio newsletter—your go-to source for innovative reagents, expert services, and insightful articles. Curated to bring you the most relevant products, services and knowledge resources, it helps you focus on what truly matters—your research.

Learn how the ASGR1 Knockout HepG2 Cell Line enables accurate validation of ASGR1-mediated uptake for GalNAc therapeutics, siRNAs, ASOs, LYTACs, and other liver-targeted drug discovery programmes.

Expand functional human NK cells with a robust, ready-to-use solution. The NK Cell Expansion Kit delivers efficient, reproducible ex vivo NK cell expansion for immuno-oncology, CAR-NK development, cytotoxicity assays, and drug screening applications.

Visualising biological structures at the nanoscale demands fluorescent probes that deliver exceptional brightness and stability under intense illumination. However, many conventional dyes suffer from photobleaching and signal loss, limiting image quality and experimental reproducibility.

Cellular senescence is involved in ageing, cancer, fibrosis and many chronic diseases. Reliable detection of senescent cells is essential for understanding disease mechanisms and evaluating therapeutic interventions. However, traditional SA-β-Gal assays can be difficult to combine with multiplex fluorescence workflows.

Building physiologically relevant 3D cell culture models requires more than advanced cell lines and innovative assay technologies. The success of organoid, spheroid and tissue-engineered models depends on creating the right microenvironment, one that closely mimics native biological conditions while ensuring reproducibility, scalability and compliance with New Approach Methodologies (NAMs).